6 | plasma albumin level | F344/DuCrlCrlj | male | 0.36 | g/l | fasting (for 16 hours) | 76891 | fasting (for 16 hours) | |

6 | plasma triglyceride level | F344/DuCrlCrlj | male | 0.9266 | mmol/l | fasting (for 16 hours) | 76897 | fasting (for 16 hours) | |

15 | plasma triglyceride level | F344/DuCrlCrlj | male | 0.55483 | mmol/l | fasting (for 16 hours) | 68964 | fasting (for 16 hours) | |

6 | blood hemoglobin level | F344/DuCrlCrlj | male | 17.5 | g/dl | fasting (for 16 hours) | 76878 | fasting (for 16 hours) | |

6 | lung wet weight | F344/DuCrlCrlj | male | 0.784 | g | specific pathogen-free conditions | 71573 | specific pathogen-free conditions | |

6 | spleen weight to body weight ratio | F344/DuCrlCrlj | male | 0.216 | % | specific pathogen-free conditions | 71582 | specific pathogen-free conditions | |

6 | mean corpuscular volume | F344/DuCrlCrlj | male | 57.7 | fl | fasting (for 16 hours) | 76880 | fasting (for 16 hours) | |

6 | body temperature | F344/DuCrlCrlj | male | 37.8 | degrees C | specific pathogen-free conditions | 74939 | specific pathogen-free conditions | |

6 | both kidneys wet weight as percentage of body weight | F344/DuCrlCrlj | male | 0.609 | % | specific pathogen-free conditions | 71578 | specific pathogen-free conditions | |

12 | retroperitoneal fat pad weight | F344/DuCrlCrlj | male | 11.7 | g | naive control condition | 12434 | naive control condition | |

15 | retroperitoneal fat pad weight | F344/DuCrlCrlj | male | 10.7 | g | naive control condition | 11414 | naive control condition | |

9 | serum triglyceride level | F344/DuCrlCrlj | male | 203.5408 | mg/dl | fasting (between 6 and 7 hours) | 11476 | fasting (between 6 and 7 hours) | |

6 | hematocrit | F344/DuCrlCrlj | male | 56.2 | % | fasting (for 16 hours) | 76879 | fasting (for 16 hours) | |

9 | blood glucose level | F344/DuCrlCrlj | male | 115.8 | mg/dl | partial pancreatectomy (70 %) | 11427 | partial pancreatectomy (70 %) | |

9 | blood glucose level | F344/DuCrlCrlj | male | 102.6 | mg/dl | naive control condition | 11426 | naive control condition | |

9 | blood glucose level | F344/DuCrlCrlj | male | 123.4 | mg/dl | partial pancreatectomy (70 %) | 11419 | partial pancreatectomy (70 %) | |

9 | blood glucose level | F344/DuCrlCrlj | male | 120.1 | mg/dl | partial pancreatectomy (70 %) | 11418 | partial pancreatectomy (70 %) | |

9 | blood glucose level | F344/DuCrlCrlj | male | 109.9 | mg/dl | partial pancreatectomy (70 %) | 11417 | partial pancreatectomy (70 %) | |

9 | blood glucose level | F344/DuCrlCrlj | male | 117.8 | mg/dl | partial pancreatectomy (70 %) | 11416 | partial pancreatectomy (70 %) | |

20 | blood glucose level | F344/DuCrlCrlj | male | 111.6 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67651 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | blood glucose level | F344/DuCrlCrlj | male | 118.8 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67650 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | blood glucose level | F344/DuCrlCrlj | male | 248.4 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67649 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | blood glucose level | F344/DuCrlCrlj | male | 334.8 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67648 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | blood glucose level | F344/DuCrlCrlj | male | 90 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67647 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

9 | blood glucose level | F344/DuCrlCrlj | male | 102.6 | mg/dl | fasting (between 6 and 7 hours) | 11479 | fasting (between 6 and 7 hours) | |

15 | blood glucose level | F344/DuCrlCrlj | male | 286.2 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11461 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 169.2 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11458 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 88.2 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11454 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 86.4 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11451 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 86.4 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11450 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 271.8 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11440 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 219.6 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11437 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 135 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11434 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 109.8 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11431 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level | F344/DuCrlCrlj | male | 91.8 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11428 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

6 | brain weight to body weight ratio | F344/DuCrlCrlj | male | 0.908 | % | specific pathogen-free conditions | 71570 | specific pathogen-free conditions | |

6 | liver weight as percentage of body weight | F344/DuCrlCrlj | male | 2.821 | % | specific pathogen-free conditions | 71576 | specific pathogen-free conditions | |

12 | mesenteric fat pad weight | F344/DuCrlCrlj | male | 11.5 | g | naive control condition | 12433 | naive control condition | |

15 | mesenteric fat pad weight | F344/DuCrlCrlj | male | 11.5 | g | naive control condition | 11413 | naive control condition | |

9 | serum total cholesterol level | F344/DuCrlCrlj | male | 81.8532 | mg/dl | fasting (between 6 and 7 hours) | 11473 | fasting (between 6 and 7 hours) | |

6 | systolic blood pressure | F344/DuCrlCrlj | male | 140 | mmHg | specific pathogen-free conditions | 74937 | specific pathogen-free conditions | |

6 | lung weight to body weight ratio | F344/DuCrlCrlj | male | 0.383 | % | specific pathogen-free conditions | 71574 | specific pathogen-free conditions | |

6 | liver wet weight | F344/DuCrlCrlj | male | 5.788 | g | specific pathogen-free conditions | 71575 | specific pathogen-free conditions | |

15 | abdominal fat pad weight | F344/DuCrlCrlj | male | 8.13 | g | fasting (for 16 hours) | 68973 | fasting (for 16 hours) | |

12 | abdominal fat pad weight | F344/DuCrlCrlj | male | 34.4 | g | naive control condition | 12436 | naive control condition | |

15 | abdominal fat pad weight | F344/DuCrlCrlj | male | 33.4 | g | naive control condition | 11412 | naive control condition | |

6 | plasma creatinine level | F344/DuCrlCrlj | male | 0.26 | mg/dl | fasting (for 16 hours) | 76900 | fasting (for 16 hours) | |

6 | plasma total cholesterol level | F344/DuCrlCrlj | male | 49 | mg/dl | fasting (for 16 hours) | 76894 | fasting (for 16 hours) | |

6 | both adrenal glands wet weight | F344/DuCrlCrlj | male | 36 | mg | specific pathogen-free conditions | 71579 | specific pathogen-free conditions | |

6 | plasma glucose level | F344/DuCrlCrlj | male | 155 | mg/dl | fasting (for 16 hours) | 76893 | fasting (for 16 hours) | |

7 | plasma glucose level | F344/DuCrlCrlj | male | 128 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13205 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) |

7 | plasma glucose level | F344/DuCrlCrlj | male | 139 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13204 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) |

7 | plasma glucose level | F344/DuCrlCrlj | male | 130.9 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13203 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) |

7 | plasma glucose level | F344/DuCrlCrlj | male | 124.1 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13202 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) |

7 | plasma glucose level | F344/DuCrlCrlj | male | 104 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13201 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) |

15 | plasma glucose level | F344/DuCrlCrlj | male | 92.6 | mg/dl | fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) | 11405 | fasting (for 12 hours) | glucose solution, 2.8M (2 g/kg) |

15 | plasma glucose level | F344/DuCrlCrlj | male | 80 | mg/dl | fasting (for 12 hours) then glucose solution, 2.8M (2 g/kg) | 11404 | fasting (for 12 hours) | glucose solution, 2.8M (2 g/kg) |

7 | plasma glucose level | F344/DuCrlCrlj | male | 128 | mg/dl | fasting (for 16 hours) then glucose solution | 67279 | fasting (for 16 hours) | glucose solution |

6 | heart rate | F344/DuCrlCrlj | male | 426 | beats/min | specific pathogen-free conditions | 74938 | specific pathogen-free conditions | |

6 | brain wet weight | F344/DuCrlCrlj | male | 1.86 | g | specific pathogen-free conditions | 71569 | specific pathogen-free conditions | |

12 | epididymal fat pad weight | F344/DuCrlCrlj | male | 11.2 | g | naive control condition | 12435 | naive control condition | |

9 | epididymal fat pad weight | F344/DuCrlCrlj | male | 10.5 | g | naive control condition | 11483 | naive control condition | |

15 | epididymal fat pad weight | F344/DuCrlCrlj | male | 11.2 | g | naive control condition | 11415 | naive control condition | |

15 | plasma glucose level | F344/DuCrlCrlj | male | 126 | mg/dl | fasting (for 16 hours) | 68962 | fasting (for 16 hours) | |

6 | mean corpuscular hemoglobin concentration | F344/DuCrlCrlj | male | 31.2 | g/dl | fasting (for 16 hours) | 76882 | fasting (for 16 hours) | |

6 | heart wet weight | F344/DuCrlCrlj | male | 0.715 | g | specific pathogen-free conditions | 71571 | specific pathogen-free conditions | |

6 | both kidneys wet weight | F344/DuCrlCrlj | male | 1.249 | g | specific pathogen-free conditions | 71577 | specific pathogen-free conditions | |

15 | blood glucose level area under curve (AUC) | F344/DuCrlCrlj | male | 12818.18169 | (mg/dl) x min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11467 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | blood glucose level area under curve (AUC) | F344/DuCrlCrlj | male | 15545.45439 | (mg/dl) x min | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 11446 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | serum insulin level | F344/DuCrlCrlj | male | 0.01247 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67658 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | serum insulin level | F344/DuCrlCrlj | male | 0.0116 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67657 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

20 | serum insulin level | F344/DuCrlCrlj | male | 0.003654 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67656 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

9 | serum insulin level | F344/DuCrlCrlj | male | 0.021924 | mg/dl | fasting (between 6 and 7 hours) | 67644 | fasting (between 6 and 7 hours) | |

15 | serum insulin level | F344/DuCrlCrlj | male | 0.0696 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67637 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | serum insulin level | F344/DuCrlCrlj | male | 0.08265 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67634 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | serum insulin level | F344/DuCrlCrlj | male | 0.01218 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67632 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | serum insulin level | F344/DuCrlCrlj | male | 0.028884 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67628 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | serum insulin level | F344/DuCrlCrlj | male | 0.071572 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67625 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

15 | serum insulin level | F344/DuCrlCrlj | male | 0.004466 | mg/dl | fasting (between 6 and 7 hours) then glucose solution (2 g/kg) | 67623 | fasting (between 6 and 7 hours) | glucose solution (2 g/kg) |

12 | body weight | F344/DuCrlCrlj | male | 393.6 | g | naive control condition | 12431 | naive control condition | |

10 | body weight | F344/DuCrlCrlj | male | 374.1 | g | fasting (for 16 hours) | 11968 | fasting (for 16 hours) | |

15 | body weight | F344/DuCrlCrlj | male | 404.4 | g | naive control condition | 11411 | naive control condition | |

6 | mean corpuscular hemoglobin level | F344/DuCrlCrlj | male | 18 | pg | fasting (for 16 hours) | 76881 | fasting (for 16 hours) | |

6 | plasma high density lipoprotein cholesterol level | F344/DuCrlCrlj | male | 29.7 | mg/dl | fasting (for 16 hours) | 76895 | fasting (for 16 hours) | |

6 | both testes wet weight | F344/DuCrlCrlj | male | 2.781 | g | specific pathogen-free conditions | 71583 | specific pathogen-free conditions | |

6 | plasma low density lipoprotein cholesterol level | F344/DuCrlCrlj | male | 3 | mg/dl | fasting (for 16 hours) | 76896 | fasting (for 16 hours) | |

6 | both testes wet weight to body weight ratio | F344/DuCrlCrlj | male | 1.354 | % | specific pathogen-free conditions | 71584 | specific pathogen-free conditions | |

6 | spleen wet weight | F344/DuCrlCrlj | male | 0.443 | g | specific pathogen-free conditions | 71581 | specific pathogen-free conditions | |

7 | blood glucose level area under curve (AUC) | F344/DuCrlCrlj | male | 15300 | (mg/dl) x min | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 67194 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) |

9 | pancreas wet weight | F344/DuCrlCrlj | male | 0.2 | g | partial pancreatectomy | 68238 | partial pancreatectomy | |

15 | serum leptin level | F344/DuCrlCrlj | male | 16.32 | ng/ml | fasting (for 16 hours) | 68971 | fasting (for 16 hours) | |

9 | pancreas weight to body weight ratio | F344/DuCrlCrlj | male | 0.892 | mg/g | partial pancreatectomy | 68240 | partial pancreatectomy | |

6 | both adrenal glands weight to body weight ratio | F344/DuCrlCrlj | male | 17.5 | mg/100g | specific pathogen-free conditions | 71580 | specific pathogen-free conditions | |

6 | body weight | F344/DuCrlCrlj | male | 218.4 | g | specific pathogen-free conditions | 70683 | specific pathogen-free conditions | |

6 | body weight | F344/DuCrlCrlj | male | 117.9 | g | specific pathogen-free conditions | 70685 | specific pathogen-free conditions | |

6 | body weight | F344/DuCrlCrlj | male | 90.6 | g | specific pathogen-free conditions | 70684 | specific pathogen-free conditions | |

9 | body weight | F344/DuCrlCrlj | male | 365 | g | naive control condition (for 185 days) | 11486 | naive control condition (for 185 days) | |

15 | body weight | F344/DuCrlCrlj | male | 207 | g | naive control condition (for 65 days) | 11465 | naive control condition (for 65 days) | |

15 | body weight | F344/DuCrlCrlj | male | 279 | g | naive control condition (for 95 days) | 11444 | naive control condition (for 95 days) | |

29 | percentage of study population developing leukemia during a period of time | F344/DuCrlCrlj | not specified | 0 | % | controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) | 70060 | controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) | |

6 | plasma urea nitrogen level | F344/DuCrlCrlj | male | 7.0686 | mmol/l | fasting (for 16 hours) | 76899 | fasting (for 16 hours) | |

15 | plasma free fatty acids level | F344/DuCrlCrlj | male | 0.654 | mmol/l | fasting (for 16 hours) | 68969 | fasting (for 16 hours) | |

29 | post-insult time to onset of T-cell lymphoma | F344/DuCrlCrlj | not specified | 106.6 | d | controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) | 70037 | controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) | |

29 | percentage of study population developing T-cell lymphomas during a period of time | F344/DuCrlCrlj | not specified | 96.6 | % | controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) | 70014 | controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) | |

6 | plasma total protein level | F344/DuCrlCrlj | male | 59 | mg/ml | fasting (for 16 hours) | 76890 | fasting (for 16 hours) | |

6 | blood basophil count to total leukocyte count ratio | F344/DuCrlCrlj | male | 0 | % | fasting (for 16 hours) | 76906 | fasting (for 16 hours) | |

6 | plasma phosphate level | F344/DuCrlCrlj | male | 7.1 | mg/dl | fasting (for 16 hours) | 76901 | fasting (for 16 hours) | |

6 | activated partial thromboplastin time | F344/DuCrlCrlj | male | 14.4 | s | fasting (for 16 hours) | 76886 | fasting (for 16 hours) | |

6 | prothrombin time | F344/DuCrlCrlj | male | 15.4 | s | fasting (for 16 hours) | 76885 | fasting (for 16 hours) | |

6 | blood eosinophil count to total leukocyte count ratio | F344/DuCrlCrlj | male | 1 | % | fasting (for 16 hours) | 76907 | fasting (for 16 hours) | |

6 | blood lymphocyte count to total leukocyte count ratio | F344/DuCrlCrlj | male | 81 | % | fasting (for 16 hours) | 76910 | fasting (for 16 hours) | |

6 | blood monocyte count to total leukocyte count ratio | F344/DuCrlCrlj | male | 5 | % | fasting (for 16 hours) | 76911 | fasting (for 16 hours) | |

6 | total plasma calcium level | F344/DuCrlCrlj | male | 10.3 | mg/dl | fasting (for 16 hours) | 76902 | fasting (for 16 hours) | |

6 | plasma alkaline phosphatase activity level | F344/DuCrlCrlj | male | 504 | IU/l | fasting (for 16 hours) | 76889 | fasting (for 16 hours) | |

6 | urine chloride level | F344/DuCrlCrlj | male | 144 | mEq/L | 0.9% sodium chloride solution (25 ml/kg) | 94874 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | urine potassium excretion rate to body weight ratio | F344/DuCrlCrlj | male | 143 | uEq/100g/6 hrs | 0.9% sodium chloride solution (25 ml/kg) | 94873 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | urine chloride excretion rate to body weight ratio | F344/DuCrlCrlj | male | 274 | uEq/100g/6 hrs | 0.9% sodium chloride solution (25 ml/kg) | 94875 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | red blood cell count | F344/DuCrlCrlj | male | 0.975 | x 10E6 cells/ul | fasting (for 16 hours) | 76877 | fasting (for 16 hours) | |

6 | white blood cell count | F344/DuCrlCrlj | male | 6.1 | x 1000 cells/ul | fasting (for 16 hours) | 76883 | fasting (for 16 hours) | |

6 | platelet count | F344/DuCrlCrlj | male | 875 | x 1000 cells/ul | fasting (for 16 hours) | 76884 | fasting (for 16 hours) | |

6 | total plasma bilirubin level | F344/DuCrlCrlj | male | 0 | mg/dl | fasting (for 16 hours) | 76898 | fasting (for 16 hours) | |

6 | plasma sodium level | F344/DuCrlCrlj | male | 148.8 | mmol/l | fasting (for 16 hours) | 76903 | fasting (for 16 hours) | |

6 | plasma potassium level | F344/DuCrlCrlj | male | 4.03 | mmol/l | fasting (for 16 hours) | 76904 | fasting (for 16 hours) | |

6 | plasma chloride level | F344/DuCrlCrlj | male | 105 | mmol/l | fasting (for 16 hours) | 76905 | fasting (for 16 hours) | |

6 | plasma aspartate aminotransferase activity level | F344/DuCrlCrlj | male | 62 | U/l | fasting (for 16 hours) | 76887 | fasting (for 16 hours) | |

6 | plasma alanine aminotransferase activity level | F344/DuCrlCrlj | male | 35 | U/l | fasting (for 16 hours) | 76888 | fasting (for 16 hours) | |

6 | urine potassium level | F344/DuCrlCrlj | male | 75.2 | mmol/l | 0.9% sodium chloride solution (25 ml/kg) | 94872 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | urine sodium level | F344/DuCrlCrlj | male | 119.6 | mmol/l | 0.9% sodium chloride solution (25 ml/kg) | 94870 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | timed urine volume | F344/DuCrlCrlj | male | 16.68 | ml/d | 0.9% sodium chloride solution (25 ml/kg) | 94868 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | urine sodium excretion rate to body weight ratio | F344/DuCrlCrlj | male | 0.006412 | uEq/min/g | 0.9% sodium chloride solution (25 ml/kg) | 94871 | 0.9% sodium chloride solution (25 ml/kg) | |

6 | timed urine volume to body weight ratio | F344/DuCrlCrlj | male | 0.0532 | ul/min/g | 0.9% sodium chloride solution (25 ml/kg) | 94869 | 0.9% sodium chloride solution (25 ml/kg) | |

15 | plasma total cholesterol level | F344/DuCrlCrlj | male | 38.61 | mg/dl | fasting (for 16 hours) | 68967 | fasting (for 16 hours) | |

9 | serum high density lipoprotein cholesterol level | F344/DuCrlCrlj | male | 37.0656 | mg/dl | fasting (between 6 and 7 hours) | 11470 | fasting (between 6 and 7 hours) | |

6 | blood segmented neutrophil count to total leukocyte count ratio | F344/DuCrlCrlj | male | 12 | % | fasting (for 16 hours) | 76909 | fasting (for 16 hours) | |

6 | plasma albumin to plasma total protein ratio | F344/DuCrlCrlj | male | 1.6 | | fasting (for 16 hours) | 76892 | fasting (for 16 hours) | |

6 | non-specified leukocyte count to total leukocyte count ratio | F344/DuCrlCrlj | male | 0 | % | fasting (for 16 hours) | 76912 | fasting (for 16 hours) | |

6 | blood band neutrophil count to total leukocyte count ratio | F344/DuCrlCrlj | male | 1 | % | fasting (for 16 hours) | 76908 | fasting (for 16 hours) | |

6 | heart weight to body weight ratio | F344/DuCrlCrlj | male | 3.49 | g/kg | specific pathogen-free conditions | 71572 | specific pathogen-free conditions | |